Literature DB >> 25977074

Recent advances in pancreatic cancer: biology, treatment, and prevention.

Divya Singh1, Ghanshyam Upadhyay2, Rakesh K Srivastava3, Sharmila Shankar4.   

Abstract

Pancreatic cancer (PC) is the fourth leading cause of cancer-related death in United States. Efforts have been made towards the development of the viable solution for its treatment with constrained accomplishment because of its complex biology. It is well established that pancreatic cancer stem cells (CSCs), albeit present in a little count, contribute incredibly to PC initiation, progression, and metastasis. Customary chemo and radiotherapeutic alternatives, however, expands general survival, the related side effects are the significant concern. Amid the most recent decade, our insight about molecular and cellular pathways involved in PC and role of CSCs in its progression has increased enormously. Presently the focus is to target CSCs. The herbal products have gained much consideration recently as they, usually, sensitize CSCs to chemotherapy and target molecular signaling involved in various tumors including PC. Some planned studies have indicated promising results proposing that examinations in this course have a lot to offer for the treatment of PC. Although preclinical studies uncovered the importance of herbal products in attenuating pancreatic carcinoma, limited studies have been conducted to evaluate their role in clinics. The present review provides a new insight to recent advances in pancreatic cancer biology, treatment and current status of herbal products in its anticipation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer prevention; Cancer stem cell; Natural Product; Pancreatic cancer; Signaling pathways

Mesh:

Year:  2015        PMID: 25977074     DOI: 10.1016/j.bbcan.2015.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

1.  Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.

Authors:  Cui-Juan Qian; Yi-Yi Chen; Xin Zhang; Fu-Qiang Liu; Ting-Ting Yue; Bei Ye; Jun Yao
Journal:  Oncol Lett       Date:  2016-09-07       Impact factor: 2.967

2.  Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.

Authors:  He Li; Heping Xiang; Weiwei Ge; Hengtong Wang; Tianpeng Wang; Maoming Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.

Authors:  Jungwhoi Lee; Jungsul Lee; Jeong-Hun Yun; Dae Gwin Jeong; Jae Hoon Kim
Journal:  Tumour Biol       Date:  2016-05-26

4.  Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.

Authors:  Majid Momeny; Zivar Alishahi; Haniyeh Eyvani; Fatemeh Esmaeili; Azam Zaghal; Parisa Ghaffari; Javad Tavakkoly-Bazzaz; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2019-09-06       Impact factor: 6.730

Review 5.  The Multiple Roles of Exosomes in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

6.  Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.

Authors:  Weijing Cai; Ranjala Ratnayake; Michael H Gerber; Qi-Yin Chen; Yichao Yu; Hartmut Derendorf; Jose G Trevino; Hendrik Luesch
Journal:  Invest New Drugs       Date:  2018-08-03       Impact factor: 3.850

7.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

8.  Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.

Authors:  Ping He; Jong Won Yang; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Gastroenterology       Date:  2017-12-15       Impact factor: 22.682

9.  SHh-Gli1 signaling pathway promotes cell survival by mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in pancreatic cancer cells.

Authors:  Huizhong Gan; Hua Liu; Hui Zhang; Yueyue Li; Xiaorong Xu; Xuanfu Xu; Jianming Xu
Journal:  Tumour Biol       Date:  2016-01-27

10.  Pancreatic cancer: Current status and Challenges.

Authors:  Amanda R Muñoz; Divya Chakravarthy; Jingjing Gong; Glenn A Halff; Rita Ghosh; Addanki P Kumar
Journal:  Curr Pharmacol Rep       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.